LINZESS was evaluated in 4 Phase 3 placebo‑controlled trials involving more than 2800 adults with IBS‑C and CIC1
*“Abdominal pain” term includes the preferred terms: abdominal pain, upper abdominal pain, and lower abdominal pain.1
Please see below and full Prescribing Information, including Boxed Warning, for additional risk information.